Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pulse Biosciences CS
(NQ:
PLSE
)
17.72
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
205
Open
17.72
Bid (Size)
17.45 (4)
Ask (Size)
17.89 (10)
Prev. Close
17.72
Today's Range
17.72 - 17.72
52wk Range
4.240 - 22.69
Shares Outstanding
54,902,942
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results
October 30, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology
October 30, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Performance
YTD
+60.80%
+60.80%
1 Month
+1.03%
+1.03%
3 Month
+18.45%
+18.45%
6 Month
+133.16%
+133.16%
1 Year
+292.04%
+292.04%
More News
Read More
Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024
October 21, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024
August 22, 2024
Via
InvestorPlace
Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday
August 13, 2024
Via
Benzinga
Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results
August 12, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors
August 12, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System
August 08, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
August 01, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024
July 29, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
July 12, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 08, 2024
Via
Benzinga
S&P 500, Nasdaq Extend Record Highs; Dow Up Triple Digits
July 08, 2024
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
July 08, 2024
Via
Benzinga
Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation
July 08, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Announces the Closing of its Rights Offering
July 03, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering
June 28, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
May 31, 2024
Via
Benzinga
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 31, 2024
Via
Benzinga
Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000
May 20, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting
May 16, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 15, 2024
Via
Benzinga
Pulse Biosciences Enhances Executive Leadership Team
May 14, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
May 09, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.